Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-010645

President and COO sold 78,355 shares at an average $117.64 ($9,217,607)

  • President and COO acquired 23,355 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Finn Patrick John · President and COO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-18 Exercise or conversion : show line 1 in the form 10b5-1 +23,355 $67.85 $1,584,637 293,033 D
2026-08-18 Sale : show line 2 in the form 10b5-1 −33,354 $115.90 $3,865,695 259,679 D
2026-08-18 Sale : show line 3 in the form 10b5-1 −10,420 $116.82 $1,217,266 249,259 D
2026-08-18 Sale : show line 4 in the form 10b5-1 −8,868 $117.70 $1,043,737 240,391 D
2026-08-18 Sale : show line 5 in the form 10b5-1 −4,500 $119.04 $535,680 235,891 D
2026-08-18 Sale : show line 6 in the form 10b5-1 −12,917 $119.86 $1,548,206 222,974 D
2026-08-18 Sale : show line 7 in the form 10b5-1 −6,296 $121.01 $761,860 216,678 D
2026-08-18 Sale : show line 8 in the form 10b5-1 −2,000 $122.58 $245,162 214,678 D
Open-market sales · 78,355 sh · avg $117.64 · $9,217,607

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-18 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −23,355 0 D
Loading xslF345X06/marketforms-73808.xml…